<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HFF69D446F8B2444EADA4D5D23E8663BE" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 5712 IH: Medicaid Drug Rebate Accountability Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-05-08</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 5712</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20180508">May 8, 2018</action-date><action-desc><sponsor name-id="S001180">Mr. Schrader</sponsor> (for himself and <cosponsor name-id="W000800">Mr. Welch</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title XIX of the Social Security Act to compel manufacturers to correct inaccurate
			 classification data reported to the Medicaid rebate program, and for other
			 purposes.</official-title></form>
	<legis-body id="H39280EEF1C5F4915BA33811B186F6326" style="OLC">
 <section id="HA6612BCB42C74EF8BC0177740BB7D661" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medicaid Drug Rebate Accountability Act</short-title></quote>.</text> </section><section id="HE0152907ECC94701AA330BA79893BF7F" section-type="subsequent-section"><enum>2.</enum><header>Authority to compel manufacturers to correct inaccurate classification data reported to Medicaid rebate program</header><text display-inline="no-display-inline">Section 1927(b)(3) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396r-8">42 U.S.C. 1396râ€“8(b)(3)</external-xref>) is amended by adding at the end the following new subparagraph:</text>
			<quoted-block display-inline="no-display-inline" id="H702EF71A47014EDBAD6C9C789269E56C" style="OLC">
				<subparagraph id="H044A94894FAC4B58AB4100DBC23FE655"><enum>(E)</enum><header>Remedy with respect to inaccurate classification data</header>
 <clause id="HCB25BE364BDF4D1B87E3BFD2CC1142CD"><enum>(i)</enum><header>Correction of inaccurate classification data</header><text display-inline="yes-display-inline">In the case that the Secretary determines that drug classification data reported on or after September 30, 2018, by a manufacturer under this paragraph, with respect to a covered outpatient drug of such manufacturer, provides an inaccurate classification for such drug, the Secretary shall require such manufacturer to correct, within a 30-day period, the classification for such drug.</text>
 </clause><clause id="HBE89E6730BBD499582266BDF6FEC96B1"><enum>(ii)</enum><header>Civil monetary penalty</header><text display-inline="yes-display-inline">In the case of a manufacturer who fails to correct the classification of a covered outpatient drug within a 30-day period pursuant to clause (i), the Secretary shall, beginning the day after the end of such 30-day period, require such manufacturer to pay a civil monetary penalty of $100,000 per day until the date on which the manufacturer corrects such classification.</text>
 </clause><clause id="H801D23E09AB846E3808FA07B4B001CEA"><enum>(iii)</enum><header>Classification defined</header><text>For purposes of this subparagraph, the term <quote>classification</quote> means identification or designation as one of the following:</text> <subclause id="H8369975631FC44BC868C12A492863FB9"><enum>(I)</enum><text>A single source drug.</text>
 </subclause><subclause id="H8040CF58ABA44821AAA76C765853B40E"><enum>(II)</enum><text>An innovator multiple source drug.</text> </subclause><subclause id="HDC61DAE765CA440295CB69E26CF52280"><enum>(III)</enum><text>A noninnovator multiple source drug.</text></subclause></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body></bill>


